Psychiatric side effects of ketamine in hospitalized medical patients administered subanesthetic doses for pain control

Acta Neuropsychiatrica

Volumn 26, Issue 4, 2014, Pages 230-233

  Rasmussen, Keith G ^a  

^a MAYO CLINIC   (United States)

Author keywords

agitation; confusion; hallucinations; ketamine; pain

Indexed keywords

KETAMINE; ANALGESIC AGENT;

ADULT; AGED; AGITATION; ARTICLE; AWARENESS; CLINICAL ARTICLE; CONFUSION; DEPRESSION; DRUG INDUCED DISEASE; DRUG INFUSION; FEMALE; GENDER; HALLUCINATION; HEALTH CARE FACILITY; HOSPITAL PATIENT; HUMAN; MALE; MEDICAL RECORD REVIEW; PAIN; RETROSPECTIVE STUDY; SEDATION; ADOLESCENT; HOSPITALIZATION; MIDDLE AGED; YOUNG ADULT; CONTINUOUS INFUSION; INFUSION; INFUSION RATE; MEDICAL RECORD; MENTAL DISEASE; OUTCOME ASSESSMENT; SIDE EFFECT; SURGICAL WARD; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANALGESICS; FEMALE; HOSPITALIZATION; HUMANS; KETAMINE; MALE; MIDDLE AGED; PAIN; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84903832526     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1017/neu.2013.61     Document Type: Article

References (12)

1. Hocking G, Cousins MJ. Ketamine in chronic pain management: An evidence-based review. Anesth Analg 2003; 97: 1730-1739
2. Noppers I, Niesters M, Aarts L, Smith T, Sarton E, Dahan A. Ketamine for the treatment of chronic non-cancer pain. Expert Opin Pharmacother 2010; 11: 2417-2429
3. Laskowski K, Stirling A, Mckay W, Lim H. A systematic review of intravenous ketamine for postoperative analgesia. Can J Anesth 2011; 58: 911-923
4. Correll GE, Maleki J, Gracely EJ, Muir JJ, Harbut RE. Subanesthetic ketamine infusion therapy: A retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Med 2004; 5: 263-275
5. Berman RM, Cappiello A, Annand A et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000; 47: 351-354
6. Rasmussen KG, Lineberry TW, Galardy CW et al. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol 2013; 27: 444-450
7. Morgan CJA, Curran HV. Ketamine use: A review. Addiction 2012; 107: 27-38
8. Krystal JH, Karper LP, Seibyl JP et al. Subanesthetic effects of the noncompetitive NMDA antagonist, Ketamine, iN humans. Psychotomimetic, pERCEPTUAL, Cognitive, aND neuroendocrine responses. Arch Gen Psychiatry 1994; 51: 199-214
9. Honey GD, Corlett PR, Absalom AR et al. Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo. J Neurosci 2008; 28: 6295-6303
10. Pomarol-Clotet E, Honey GD, Murray GK et al. Psychological effects of ketamine in healthy volunteers: Phenomenological study. Br J Psychiatry 2006; 189: 173-179
11. Bowdle TA, Radant AD, Cowley DS, Kharasch ED, Strassman RJ, Roy-BYRNE PP. Psychedelic effects of ketamine in healthy volunteers. Relationship to steadystate plasma concentrations. Anesthesiology 1998; 88: 82-88
12. Gouzoulis-Mayfrank E, Heekeren K, Neukirch A et al. Psychological effects of (S)-ketamine and N, Ndimethyltryptamine (DMT): A double-blind, cROSS-over study in healthy volunteers. Pharmacopsychiatry 2005; 38: 301-311